SHL TELEMEDICINE LTD-ADR (SHLT) Fundamental Analysis & Valuation

NASDAQ:SHLT • US78423T2006

Current stock price

2.05 USD
-0.03 (-1.44%)
Last:

This SHLT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SHLT Profitability Analysis

1.1 Basic Checks

  • In the past year SHLT has reported negative net income.
  • SHLT had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SHLT reported negative net income in multiple years.
  • In multiple years SHLT reported negative operating cash flow during the last 5 years.
SHLT Yearly Net Income VS EBIT VS OCF VS FCFSHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

  • SHLT's Return On Assets of -8.60% is on the low side compared to the rest of the industry. SHLT is outperformed by 71.96% of its industry peers.
  • SHLT has a Return On Equity of -13.13%. This is in the lower half of the industry: SHLT underperforms 62.62% of its industry peers.
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROIC N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
SHLT Yearly ROA, ROE, ROICSHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

  • The Gross Margin of SHLT (45.73%) is better than 73.83% of its industry peers.
  • SHLT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SHLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
SHLT Yearly Profit, Operating, Gross MarginsSHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SHLT Health Analysis

2.1 Basic Checks

  • SHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SHLT has been increased compared to 1 year ago.
  • Compared to 1 year ago, SHLT has an improved debt to assets ratio.
SHLT Yearly Shares OutstandingSHLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
SHLT Yearly Total Debt VS Total AssetsSHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

  • SHLT has an Altman-Z score of -0.08. This is a bad value and indicates that SHLT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of SHLT (-0.08) is worse than 76.64% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that SHLT is not too dependend on debt financing.
  • SHLT has a better Debt to Equity ratio (0.20) than 69.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC7.08%
SHLT Yearly LT Debt VS Equity VS FCFSHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.17 indicates that SHLT has no problem at all paying its short term obligations.
  • SHLT has a Current ratio of 2.17. This is in the better half of the industry: SHLT outperforms 76.64% of its industry peers.
  • A Quick Ratio of 1.98 indicates that SHLT should not have too much problems paying its short term obligations.
  • The Quick ratio of SHLT (1.98) is better than 74.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.98
SHLT Yearly Current Assets VS Current LiabilitesSHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SHLT Growth Analysis

3.1 Past

  • The earnings per share for SHLT have decreased strongly by -282.35% in the last year.
  • SHLT shows a decrease in Revenue. In the last year, the revenue decreased by -2.04%.
  • SHLT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.16% yearly.
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SHLT Yearly Revenue VS EstimatesSHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
SHLT Yearly EPS VS EstimatesSHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. SHLT Valuation Analysis

4.1 Price/Earnings Ratio

  • SHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHLT Price Earnings VS Forward Price EarningsSHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHLT Per share dataSHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SHLT Dividend Analysis

5.1 Amount

  • SHLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SHLT Fundamentals: All Metrics, Ratios and Statistics

SHL TELEMEDICINE LTD-ADR

NASDAQ:SHLT (4/2/2025, 8:00:02 PM)

2.05

-0.03 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)04-24
Inst Owners27.15%
Inst Owner Change0%
Ins Owners5.8%
Ins Owner Change0%
Market Cap33.60M
Revenue(TTM)55.94M
Net Income(TTM)-8.84M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF 23.16
P/B 0.5
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.09
OCFY4.32%
SpS3.41
BVpS4.11
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.73%
FCFM N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.04%
Cap/Sales 9.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.98
Altman-Z -0.08
F-Score5
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)76.24%
Cap/Depr(5y)63.01%
Cap/Sales(3y)9.3%
Cap/Sales(5y)7.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.12%
OCF growth 3YN/A
OCF growth 5YN/A

SHL TELEMEDICINE LTD-ADR / SHLT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SHL TELEMEDICINE LTD-ADR?

ChartMill assigns a fundamental rating of 2 / 10 to SHLT.


What is the valuation status of SHL TELEMEDICINE LTD-ADR (SHLT) stock?

ChartMill assigns a valuation rating of 0 / 10 to SHL TELEMEDICINE LTD-ADR (SHLT). This can be considered as Overvalued.


Can you provide the profitability details for SHL TELEMEDICINE LTD-ADR?

SHL TELEMEDICINE LTD-ADR (SHLT) has a profitability rating of 1 / 10.